Scientists who pioneered arthritis drug# Biology - 生物学
s*n
1 楼
The scientific duo of Ray Goodwin and Craig Smith, who made early
breakthroughs that led to the creation of the arthritis drug Enbrel, has been
split up. Both quietly resigned in the past few weeks, a year after biotech
giant Amgen bought Seattle-based Immunex.
Goodwin and Smith, both 52, said they stayed this long to receive one-year
retention bonuses from Amgen and left with no fanfare other than a beer or two
with close colleagues.
The departures were not a shock — they are the latest in a st
breakthroughs that led to the creation of the arthritis drug Enbrel, has been
split up. Both quietly resigned in the past few weeks, a year after biotech
giant Amgen bought Seattle-based Immunex.
Goodwin and Smith, both 52, said they stayed this long to receive one-year
retention bonuses from Amgen and left with no fanfare other than a beer or two
with close colleagues.
The departures were not a shock — they are the latest in a st